Vascular Imaging Market: Market Size & Forecast 2026

Vascular imaging refers to non-invasive and minimally invasive diagnostic modalities used to evaluate arteries, veins, and the lymphatic system, including ultrasound (Doppler), CT angiography (CTA), MR angiography (MRA), and conventional catheter-based angiography. The global market is currently estimated at approximately USD 5.59 billion in 2025, with independent analyst forecasts placing its 2030 value in a broad range of roughly USD 7.5-10 billion, reflecting differing scope definitions across research firms. The category is closely tied to broader medical imaging and cardiovascular diagnostics markets, which significantly exceed this value.

• •2025 market size estimated at USD 5.59 billion with a projected 5.54% CAGR.
• •Key modalities: Doppler/ultrasound, CT angiography, MR angiography, and catheter-based angiography.
• •Forecast endpoints diverge by methodology, ranging from ~USD 7.5 billion to over USD 10 billion by 2030.

The principal growth driver is the rising global burden of cardiovascular disease, which remains the leading cause of mortality worldwide and continues to increase in prevalence in low- and middle-income countries. Aging populations in North America, Europe, and East Asia are expanding the pool of patients requiring diagnosis of atherosclerosis, aneurysms, and venous disease, while rising rates of diabetes, obesity, and hypertension further elevate demand. Technological progress in non-invasive imaging, including faster CT scanners, improved MR sequences, AI-assisted image interpretation, and more compact point-of-care ultrasound, is broadening clinical adoption.

• •Aging demographics and rising prevalence of cardiovascular, cerebrovascular, and peripheral vascular disease.
• •Growing incidence of diabetes, obesity, and hypertension, all of which elevate vascular risk.
• •Advances in non-invasive modalities and AI-enabled image analysis that expand clinical utility.

By technology, the market is segmented into ultrasound, CT, MRI, nuclear medicine, and X-ray/catheter angiography, with ultrasound and CT angiography typically accounting for the largest revenue shares because of their speed, cost, and broad availability. By application, diagnostic imaging of coronary artery disease, stroke, peripheral artery disease, and venous thrombosis represent the core clinical use cases. Geographically, North America holds the leading share due to high healthcare spending, established reimbursement, and the early adoption of advanced systems, while Asia-Pacific is the fastest-growing region on the back of healthcare investment in China, India, Japan, and South Korea.

• •Ultrasound and CT angiography are the largest technology segments, followed by MRI and nuclear imaging.
• •Major applications include coronary artery disease, stroke, peripheral artery disease, and venous thromboembolism.
• •North America leads in revenue; Asia-Pacific is the fastest-growing regional market.

What are the recent trends and outlook?

The most significant near-term trend is the integration of artificial intelligence into vascular imaging workflows, enabling automated vessel segmentation, plaque characterization, and quantitative reporting that shorten interpretation time and improve reproducibility. Hybrid imaging systems that combine CT or MR with PET are gaining traction in complex cardiovascular and oncologic vascular indications, and there is growing interest in photon-counting CT for ultra-high-resolution vascular studies. Over the forecast period, demand is expected to be strongest in emerging markets where healthcare infrastructure is expanding, while mature markets will see growth driven by replacement of older systems and software-led upgrades.

• •AI-assisted image acquisition, reconstruction, and interpretation is becoming a standard differentiator.
• •Hybrid and photon-counting imaging systems are broadening clinical capability at the high end.
• •Emerging markets, particularly in Asia-Pacific, are expected to deliver the strongest incremental growth.